| ADR Ontology |
| ADR Term |
Acquired immunodeficiency syndromes |
| ADR ID |
BADD_A05174 |
| ADR Hierarchy |
|
| Description |
An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. [MeSH] |
| MedDRA Code |
10052740 |
| MeSH ID |
D000163
|
|
ADR Severity Grade (FAERS)
|
|
|
ADR Severity Grade (CTCAE)
|
Not Available
|
| Synonym |
| Acquired Immunodeficiency Syndrome | Immunologic Deficiency Syndrome, Acquired | Acquired Immune Deficiency Syndrome | Acquired Immuno-Deficiency Syndrome | Acquired Immuno Deficiency Syndrome | Acquired Immuno-Deficiency Syndromes | Immuno-Deficiency Syndrome, Acquired | Immuno-Deficiency Syndromes, Acquired | Syndrome, Acquired Immuno-Deficiency | Syndromes, Acquired Immuno-Deficiency | Immunodeficiency Syndrome, Acquired | Acquired Immunodeficiency Syndromes | Immunodeficiency Syndromes, Acquired | Syndrome, Acquired Immunodeficiency | Syndromes, Acquired Immunodeficiency | AIDS |
|
|
| Drugs Leading to the ADR |
| Drug ID | Drug Name | ADR Frequency (FAERS) | ADR Severity Grade (FAERS) | | BADD_D02464 | Fingolimod | 0.000241% | |
| The 2th Page First
Pre
2
Total 2 Pages
|
|
